Private Wealth Partners, LLC Novartis Ag Transaction History

Private Wealth Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$95.27 - $108.47 $5,335 - $6,074	56 Added 2.21%	2,590 $250,000
Q1 2023 May 03, 2023	BUY	$80.03 - $92.81 $202,796 - $235,180	2,534 New	2,534 $233,000
Q1 2021 May 04, 2021	SELL	$83.5 - $98.47 $273,546 - $322,587	-3,276 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$78.07 - $94.43 $72,058 - $87,158	-923 Reduced 21.98%	3,276 $309,000
Q4 2019 Jan 29, 2020	BUY	$84.35 - $95.37 $95,315 - $107,768	1,130 Added 36.82%	4,199 $398,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $128,310 - $141,390	-1,500 Reduced 32.83%	3,069 $267,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $87,464 - $107,648	-1,160 Reduced 20.25%	4,569 $417,000
Q1 2019 May 02, 2019	BUY	$75.32 - $86.15 $431,508 - $493,553	5,729 New	5,729 $551,000
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $1.51 Million - $1.62 Million	-20,900 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $1.55 Million - $1.61 Million	20,900	20,900 $1.79 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Wealth Partners, LLC with notifications on news.